ARTICLE | Financial News
Epimmune doubles on HBV publication
January 17, 2001 8:00 AM UTC
EPMN was up $2.563 (103 percent) to $5.063 on Wednesday after the company announced a publication in the Journal of Immunology on use of HBV epitopes that activate cytotoxic T cells to overcome immun...